Mostrar el registro sencillo del ítem
dc.contributor.author | Beltrán López, Cristian Sanctus Angeluz | |
dc.contributor.author | Gonzales Dagua, William Fernando | |
dc.date.accessioned | 2019-01-17T16:11:18Z | |
dc.date.available | 2019-01-17T16:11:18Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Vancouver | |
dc.identifier.uri | http://repositorio.unicauca.edu.co:8080/xmlui/handle/123456789/597 | |
dc.description.abstract | ANTECEDENTES: La sepsis es un síndrome clínico que complica infecciones severas, cuya incidencia es muy alta. Los corticoides han sido un objetivo particular de análisis por su amplia influencia en la respuesta inmunológica de estos pacientes. Existen discrepancias respecto a la indicación de los corticoides en el choque séptico. Esta revisión realiza una búsqueda actualizada de la evidencia respecto al efecto corticoide sobre la mortalidad en pacientes con choque séptico, entre otros resultados. OBJETIVO: Determinar la eficacia de los corticoides en la mortalidad global de los pacientes en choque séptico. ESTRATEGIA DE BUSQUEDA: La búsqueda se hizo en la base de datos MEDLINE, desde enero de 2002 hasta febrero de 2013, incluyendo ensayos clínicos controlados aleatorizados. EXTRACCIÓN Y ANALISIS DE LOS DATOS: La selección de los estudios se realizó por parte de dos revisores independientemente. Para evaluación de sesgos se evitó el uso de escalas con puntuación resumen. RESULTADOS: A los 28 días, no hubo diferencia significativa en la mortalidad entre los pacientes en los dos grupos de estudio. No se encontró reducción significativa en la mortalidad. El momento de la retirada vasopresor fue más corto en el grupo de tratamiento en comparación con el placebo. CONCLUSIONES DE LOS AUTORES: Los corticoides no impactaron la mortalidad a 28 días por todas las causas en el choque séptico en el global de los pacientes. La reversión de la condición de choque fue más rápida y la duración media en UCI fue más corta en los pacientes con manejo corticoide. | spa |
dc.description.abstract | BACKGROUND: Sepsis is a clinical syndrome that complicates severe infections, whose incidence is very high. Corticosteroids have been a particular object of analysis for its wide influence on the immune response in these patients. There are discrepancies regarding the indication of corticosteroids in septic shock. This review takes an updated search of evidence regarding corticosteroid effect on mortality in patients with septic shock, among other results. OBJECTIVE: To determine the efficacy of corticosteroids in overall mortality in septic shock patients. SEARCH STRATEGY: A search was conducted in MEDLINE database from January 2002 to February 2013, including randomized controlled trials. EXTRACTION AND DATA ANALYSIS: The selection of studies was performed by two reviewers independently. For assessment of bias was avoided using scales with scoring summary. RESULTS: At 28 days, there was no significant difference in mortality between patients in the two study groups. There was no significant reduction in mortality. The time of removal was shorter vasopressor treatment group compared to placebo. AUTHOR’S CONCLUSIONS: Corticosteroids did not impact on 28-day mortality from all causes in septic shock in patients overall. Reversing the crash condition was faster and the average length was shorter ICU patients on steroid use. | eng |
dc.language.iso | spa | spa |
dc.publisher | Universidad del Cauca | spa |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Sepsis | spa |
dc.subject | Choque séptico | spa |
dc.subject | Corticoide | spa |
dc.subject | Mortalidad | spa |
dc.title | Corticoides para mejorar la mortalidad en choque séptico : Revisión narrativa con rigor metodológico | spa |
dc.type | Tesis de especialización | spa |
dc.rights.creativecommons | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.type.driver | info:eu-repo/semantics/other | |
dc.type.coar | http://purl.org/coar/resource_type/c_1843 | |
dc.publisher.faculty | Facultad Ciencias de la Salud | spa |
dc.publisher.program | Especialización en Medicina Interna | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dc.coar.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |
dc.description.abstractenglish | BACKGROUND: Sepsis is a clinical syndrome that complicates severe infections, whose incidence is very high. Corticosteroids have been a particular object of analysis for its wide influence on the immune response in these patients. There are discrepancies regarding the indication of corticosteroids in septic shock. This review takes an updated search of evidence regarding corticosteroid effect on mortality in patients with septic shock, among other results. OBJECTIVE: To determine the efficacy of corticosteroids in overall mortality in septic shock patients. SEARCH STRATEGY: A search was conducted in MEDLINE database from January 2002 to February 2013, including randomized controlled trials. EXTRACTION AND DATA ANALYSIS: The selection of studies was performed by two reviewers independently. For assessment of bias was avoided using scales with scoring summary. RESULTS: At 28 days, there was no significant difference in mortality between patients in the two study groups. There was no significant reduction in mortality. The time of removal was shorter vasopressor treatment group compared to placebo. AUTHOR’S CONCLUSIONS: Corticosteroids did not impact on 28-day mortality from all causes in septic shock in patients overall. Reversing the crash condition was faster and the average length was shorter ICU patients on steroid use. | en |
dc.identifier.instname | ||
dc.identifier.reponame | ||
oaire.accessrights | ||
dc.identifier.repourl | ||
oaire.version |